News ICON Public Limited Company

Stocks

ICLR

IE0005711209

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 04:01:02 2026-06-12 pm EDT			5-day change	1st Jan Change
151.06 ^USD	+0.76%		-1.80%	-19.46%

Jun. 01	Analyst recommendations: Caesars Entertainment, Dell Technologies, AMD, Dycom Industries…
May. 29	Truist Raises Price Target on ICON to $159 From $139, Keeps Hold Rating	MT

All News

Mentions Relevance

May. 29	Truist Raises Price Target on ICON to $159 From $139, Keeps Hold Rating	MT
May. 29	RBC Raises Price Target on ICON to $126 From $123, Keeps Sector Perform Rating	MT
May. 28	ICON Public Limited Company, Q4 2025 Earnings Call, May 28, 2026
May. 28	Icon Public Limited Company Provides Earnings Guidance for the Full Year 2026	CI
May. 28	Deutsche Bank Adjusts ICON Price Target to $180 From $160, Maintains Buy Rating	MT
May. 27	ICON Fiscal Q4 Adjusted Earnings Fall, Revenue Rises	MT
May. 27	Icon PLC: Q4 Earnings Snapshot	AQ
May. 27	ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation	BU
May. 27	ICON plc Announces Board Changes	CI
May. 27	Tranche Update on ICON Public Limited Company's Equity Buyback Plan announced on February 19, 2025.	CI
May. 27	ICON Public Limited Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
May. 26	ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq	BU
May. 18	Icon Set to Benefit From Rising Clinical Trial Activity, Strong Relationships With Large Pharma, RBC Says	MT
May. 13	Icon expands US early phase research capabilities with new clinic and outpatient centres	RE
May. 13	Icon Opens New Clinical Facilities in Move to Expand Early-Phase Capabilities	MT
May. 13	ICON expands US early phase research capabilities with new clinic and outpatient centres	BU
May. 13	Icon plc Expands Early Phase Research Capabilities with New Clinic and Outpatient Centres	CI
Apr. 29	ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results	BU
Mar. 24	Icon, Advarra Collaborate to Develop Site Network Model for Clinical Trials	MT
Mar. 24	ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model	BU
Mar. 24	Icon and Advarra Introduce New Research-Ready Connected Site Network Model	CI
Mar. 16	Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm	AQ
Mar. 10	An undisclosed buyer acquired an unknown minority stake in ICON Public Limited Company from Polen Capital Management, LLC.	CI
Feb. 23	ICON Shares Rise After Jefferies Upgrade	MT
Feb. 23	Jefferies Upgrades ICON to Buy From Hold, Adjusts Price Target to $135 From $175	MT